156 related articles for article (PubMed ID: 25464433)
1. Flow-mediated dilation is associated with cardiovascular events in non-valvular atrial fibrillation patients.
Perri L; Pastori D; Pignatelli P; Violi F; Loffredo L
Int J Cardiol; 2015 Jan; 179():139-43. PubMed ID: 25464433
[TBL] [Abstract][Full Text] [Related]
2. Long-term association of brachial artery flow-mediated vasodilation and cardiovascular events in middle-aged subjects with no apparent heart disease.
Shechter M; Issachar A; Marai I; Koren-Morag N; Freinark D; Shahar Y; Shechter A; Feinberg MS
Int J Cardiol; 2009 May; 134(1):52-8. PubMed ID: 18479768
[TBL] [Abstract][Full Text] [Related]
3. Urinary 11-dehydro-thromboxane B2 is associated with cardiovascular events and mortality in patients with atrial fibrillation.
Pastori D; Pignatelli P; Farcomeni A; Cangemi R; Hiatt WR; Bartimoccia S; Nocella C; Vicario T; Bucci T; Carnevale R; Lip GY; Violi F
Am Heart J; 2015 Sep; 170(3):490-7.e1. PubMed ID: 26385032
[TBL] [Abstract][Full Text] [Related]
4. Incidence of myocardial infarction and vascular death in elderly patients with atrial fibrillation taking anticoagulants: relation to atherosclerotic risk factors.
Pastori D; Pignatelli P; Angelico F; Farcomeni A; Del Ben M; Vicario T; Bucci T; Raparelli V; Cangemi R; Tanzilli G; Lip GYH; Violi F
Chest; 2015 Jun; 147(6):1644-1650. PubMed ID: 25429521
[TBL] [Abstract][Full Text] [Related]
5. Inadequate anticoagulation by Vitamin K Antagonists is associated with Major Adverse Cardiovascular Events in patients with atrial fibrillation.
Pastori D; Pignatelli P; Saliola M; Carnevale R; Vicario T; Del Ben M; Cangemi R; Barillà F; Lip GY; Violi F
Int J Cardiol; 2015 Dec; 201():513-6. PubMed ID: 26318513
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of brachial artery flow-mediated dilation to predict long-term cardiovascular events in subjects without heart disease.
Shechter M; Shechter A; Koren-Morag N; Feinberg MS; Hiersch L
Am J Cardiol; 2014 Jan; 113(1):162-7. PubMed ID: 24169007
[TBL] [Abstract][Full Text] [Related]
7. Cholesterol-adjusted vitamin E serum levels are associated with cardiovascular events in patients with non-valvular atrial fibrillation.
Cangemi R; Pignatelli P; Carnevale R; Corazza GR; Pastori D; Farcomeni A; Basili S; Davì G; Ferro D; Hiatt WR; Licata G; Lip GY; Loffredo L; Mannucci PM; Vestri A; Violi F;
Int J Cardiol; 2013 Oct; 168(4):3241-7. PubMed ID: 23651827
[TBL] [Abstract][Full Text] [Related]
8. The impact of early compared to late morning hours on brachial endothelial function and long-term cardiovascular events in healthy subjects with no apparent coronary heart disease.
Hirsch L; Shechter A; Feinberg MS; Koren-Morag N; Shechter M
Int J Cardiol; 2011 Sep; 151(3):342-7. PubMed ID: 20832878
[TBL] [Abstract][Full Text] [Related]
9. Impaired flow mediated dilatation as evidence of endothelial dysfunction in chronic atrial fibrillation: relationship to plasma von Willebrand factor and soluble E-selectin levels.
Freestone B; Chong AY; Nuttall S; Lip GY
Thromb Res; 2008; 122(1):85-90. PubMed ID: 17996280
[TBL] [Abstract][Full Text] [Related]
10. The CHADS2 and CHA2DS2-VASc scores predict adverse vascular function, ischemic stroke and cardiovascular death in high-risk patients without atrial fibrillation: role of incorporating PR prolongation.
Chan YH; Yiu KH; Lau KK; Yiu YF; Li SW; Lam TH; Lau CP; Siu CW; Tse HF
Atherosclerosis; 2014 Dec; 237(2):504-13. PubMed ID: 25463082
[TBL] [Abstract][Full Text] [Related]
11. Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease: additive value of flow-mediated dilation to ankle-brachial pressure index.
Brevetti G; Silvestro A; Schiano V; Chiariello M
Circulation; 2003 Oct; 108(17):2093-8. PubMed ID: 14530195
[TBL] [Abstract][Full Text] [Related]
12. Brachial flow-mediated dilation and incident atrial fibrillation: the multi-ethnic study of atherosclerosis.
O'Neal WT; Efird JT; Yeboah J; Nazarian S; Alonso A; Heckbert SR; Soliman EZ
Arterioscler Thromb Vasc Biol; 2014 Dec; 34(12):2717-20. PubMed ID: 25341797
[TBL] [Abstract][Full Text] [Related]
13. Adverse cardiovascular outcomes in atrial fibrillation: Validation of the new 2MACE risk score.
Polovina M; Đikić D; Vlajković A; Vilotijević M; Milinković I; Ašanin M; Ostojić M; Coats AJS; Seferović PM
Int J Cardiol; 2017 Dec; 249():191-197. PubMed ID: 28986061
[TBL] [Abstract][Full Text] [Related]
14. Combination of Flow-Mediated Vasodilation and Nitroglycerine-Induced Vasodilation Is More Effective for Prediction of Cardiovascular Events.
Kajikawa M; Maruhashi T; Hida E; Iwamoto Y; Matsumoto T; Iwamoto A; Oda N; Kishimoto S; Matsui S; Hidaka T; Kihara Y; Chayama K; Goto C; Aibara Y; Nakashima A; Noma K; Higashi Y
Hypertension; 2016 May; 67(5):1045-52. PubMed ID: 26975705
[TBL] [Abstract][Full Text] [Related]
15. Relevance of uric acid and asymmetric dimethylarginine for modeling cardiovascular risk prediction in chronic kidney disease patients.
Kanbay M; Afsar B; Siriopol D; Unal HU; Karaman M; Saglam M; Eyileten T; Gezer M; Verim S; Oguz Y; Vural A; Ortiz A; Johnson RJ; Covic A; Yilmaz MI
Int Urol Nephrol; 2016 Jul; 48(7):1129-36. PubMed ID: 27007614
[TBL] [Abstract][Full Text] [Related]
16. Impaired endothelial function in lone atrial fibrillation.
Polovina M; Potpara T; Giga V; Stepanović J; Ostojić M
Vojnosanit Pregl; 2013 Oct; 70(10):908-14. PubMed ID: 24313171
[TBL] [Abstract][Full Text] [Related]
17. Impaired brachial flow-mediated dilation is a predictor of a new-onset vascular event after stroke.
Santos-García D; Blanco M; Serena J; Rodríguez-Yáñez M; Leira R; Castillo J
Cerebrovasc Dis; 2011; 32(2):155-62. PubMed ID: 21778713
[TBL] [Abstract][Full Text] [Related]
18. Relationship between Mediterranean diet and time in therapeutic range in atrial fibrillation patients taking vitamin K antagonists.
Pignatelli P; Pastori D; Vicario T; Bucci T; Del Ben M; Russo R; Tanzilli A; Nardoni ML; Bartimoccia S; Nocella C; Ferro D; Saliola M; Cangemi R; Lip GY; Violi F
Europace; 2015 Aug; 17(8):1223-8. PubMed ID: 25995397
[TBL] [Abstract][Full Text] [Related]
19. Reply to "The relation between flow mediated dilation and atrial fibrillation" by S. Balta: Refers to Sevket Balta, MD et al.
Perri L; Pastori D; Pignatelli P; Violi F; Loffredo L
Int J Cardiol; 2015 Dec; 201():225-6. PubMed ID: 26301641
[No Abstract] [Full Text] [Related]
20. Ankle-Brachial Index and cardiovascular events in atrial fibrillation. The ARAPACIS Study.
Violi F; Davì G; Proietti M; Pastori D; Hiatt WR; Corazza GR; Perticone F; Pignatelli P; Farcomeni A; Vestri AR; Lip GY; Basili S;
Thromb Haemost; 2016 Apr; 115(4):856-63. PubMed ID: 26740316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
